These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7282307)

  • 1. Cyproterone acetate in the treatment of hirsutism.
    Ylöstalo P; Laakso L; Viinikka L; Ylikorkala O; Vihko R
    Acta Obstet Gynecol Scand; 1981; 60(4):399-401. PubMed ID: 7282307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M; Lachinsky N; Moolenaar AJ
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of female hirsutism with the anti-androgen agent cyproterone.
    Kwok PC; Correy JF; Senator GB
    Asia Oceania J Obstet Gynaecol; 1985 Jun; 11(2):233-40. PubMed ID: 4038178
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of essential hirsutism in women with cyproterone acetate and ethinyl estradiol. Clinical and endocrine effects in 10 cases.
    Frey H; Aakvaag A
    Acta Obstet Gynecol Scand; 1981; 60(3):295-300. PubMed ID: 6455899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of (1) cyproterone acetate and (2) ethinyl oestradiol and lynoestrenol (Minilyn) in the treatment of idiopathic hirsutism.
    Anderson JA
    Br J Dermatol; 1978 Nov; 99(5):545-52. PubMed ID: 708628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyproterone acetate as initial treatment and maintenance therapy for hirsutism.
    Holdaway IM; Croxson MS; Ibbertson HK; Sheehan A; Knox B; France J
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):522-9. PubMed ID: 2930987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of reverse sequential anti-androgen therapy (cyproterone acetate and ethinyl estradiol) on hematological parameters.
    Parr JH; Seed M; Godsland I; Wynn V
    J Endocrinol Invest; 1987 Jun; 10(3):237-9. PubMed ID: 2957418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
    Rubens R
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):313-25. PubMed ID: 6233049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of long-term treatment with cyproterone acetate or a cyproterone acetate-ethinyl oestradiol combination on androgen levels in blood of hirsute women.
    Frölich M; Vader HL; Walma ST; De Rooy HA
    J Steroid Biochem; 1980 Jan; 12():499-501. PubMed ID: 6448324
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
    Barth JH; Cherry CA; Wojnarowska F; Dawber RP
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):5-10. PubMed ID: 1832346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
    Porcile A; Gallardo E
    Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol.
    Jones DB; Ibraham I; Edwards CR
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):497-501. PubMed ID: 2962412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyproterone acetate: a study involving two volunteers with idiopathic hirsutism.
    Barnes EW; Irvine WJ; Hunter WM; Ismail AA
    Clin Endocrinol (Oxf); 1975 Jan; 4(1):65-73. PubMed ID: 1122656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-androgen treatment of hirsutism with cyproterone acetate].
    Kása M; Egyedi K; Raffai S; Török L
    Z Hautkr; 1990 Dec; 65(12):1112-4. PubMed ID: 2150902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyproterone acetate. 15 cases of hirsutism treated for 1 year].
    Houdent C; Kuhn JM; Balacheff O; Leclerc P; Legrand A; Wolf LM
    Ann Endocrinol (Paris); 1983; 44(6):397-401. PubMed ID: 6234850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse of hirsutism following long-term successful treatment with oestrogen-progestogen combination.
    Kokaly W; McKenna TJ
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):379-82. PubMed ID: 10718837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.
    Sahin Y; Bayram F; Keleştimur F; Müderris I
    J Endocrinol Invest; 1998 Jun; 21(6):348-52. PubMed ID: 9699125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyproterone acetate for hirsutism.
    Van der Spuy ZM; le Roux PA
    Cochrane Database Syst Rev; 2003; 2003(4):CD001125. PubMed ID: 14583927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe hirsutism resulting from hyperandrogenism with the reverse sequential cyproterone acetate regimen.
    Garner PR; Poznanski N
    J Reprod Med; 1984 Apr; 29(4):232-6. PubMed ID: 6232380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.